About Strand Diagnostics
Strand Diagnostics is a company based in Indianapolis (United States) founded in 2008. Strand Diagnostics has raised $30 million across 1 funding round from investors including NantWorks. Strand Diagnostics operates in a competitive market with competitors including Veritas Genetics, GreenLight Biosciences, Kailos, Genesis Healthcare and Yunhu Technology Group, among others.
- Headquarter Indianapolis, United States
- SectorsHealthcare
- Website stranddiagnostics.com
- Social LinkedIn
- Legal Name Strand Diagnostics, Llc.
- Total Equity Funding$30M (USD)
in 1 rounds
- Latest Funding Round$30M (USD), Series A
Mar 2012
- Investors
Funding Insights of Strand Diagnostics
Strand Diagnostics has successfully raised a total of $30M through 1 strategic funding round. The most recent funding activity was a Series A round of $30 million completed in March 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $30M
- Total Rounds 1
- Last Round Series A — $30M
- First Round $30M
(Mar 2012)
- Investors Count 1
All 1 funding rounds of Strand Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2012 | $30M | Series A | – | – |
1 investors in total: 1 institutional.
Investors in Strand Diagnostics
Strand Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include NantWorks.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Network of technology and infrastructure companies focused on healthcare development | 2006 | nantworks.com | Culver City, United States |
Investor details for Strand Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Strand Diagnostics
2 dated milestones of Strand Diagnostics across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Strand Diagnostics is founded.
- Funding First funding round of $30.0M.
Competitors of Strand Diagnostics
Strand Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Veritas Genetics, GreenLight Biosciences, Kailos, Genesis Healthcare and Yunhu Technology Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| veritasgenetics.com | 2014 | Danvers, United States | $53.38M | 14 | Genetic testing products for health risks and traits are offered. | |
| greenlightbiosciences.com | 2008 | Lexington, United States | $225.05M | 287 | RNA-based platform for life sciences is developed by GreenLight Biosciences. | |
| kailosgenetics.com | 2010 | Huntsville, United States | $3.9M | 10 | Provider of consumer-based genetic testing services | |
| genesis-healthcare.jp | 2004 | Tokyo, Japan | $29.25M | – | Provider of consumer kits and genomic services for researchers | |
| yunhuyj.com | 2017 | Hangzhou, China | $38.05M | – | DNA testing services are provided via an online platform. | |
| ravgen.com | 2000 | Columbia, United States | – | – | Fetal DNA in maternal blood is analyzed for prenatal diagnostics. | |
| arcpointlabs.com | 2005 | Greenville, United States | – | – | Provider of genetic testing services | |
| genebygene.com | 2000 | Houston, United States | – | 196 | DNA testing for ancestry, genealogy, and health is offered. | |
| lifegenomics.se | 2014 | Gothenburg, Sweden | – | – | Genetic tests for fetal health and personal wellness are developed. |
Detailed competitors of Strand Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Strand Diagnostics
Complete news archive for Strand Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Strand Diagnostics
10 companies that operate in the same segment as Strand Diagnostics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Strand Diagnostics
Strand Diagnostics was founded in 2008 and raised its 1st funding round 4 years after it was founded.
Strand Diagnostics is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.
Strand Diagnostics is a funded company, having raised a total of $30M across 1 funding round to date. The company's 1st funding round was a Series A of $30M, raised on Mar 2012.
Strand Diagnostics was founded in 2008 in Indianapolis, United States, with a focus on diagnostics and forensic technologies. The company has created a system employing bar coding, forensic methods, and DNA matching to verify surgical biopsy samples. This approach is applied in U.S. medical fields such as breast surgery, radiology, urology, gastroenterology, and oncology. DNA Specimen Provenance Assignment testing is also offered to support diagnostic processes prior to treatment.
Strand Diagnostics's top competitors include GreenLight Biosciences, Veritas Genetics and ARCpoint Labs.
Strand Diagnostics has 1 investor. Key investors include NantWorks.
Strand Diagnostics operates through Strand Diagnostics, Llc..